These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 33718461)

  • 1. Type 2 Diabetes and Myocardial Infarction: Recent Clinical Evidence and Perspective.
    Cui J; Liu Y; Li Y; Xu F; Liu Y
    Front Cardiovasc Med; 2021; 8():644189. PubMed ID: 33718461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between angiotensin-converting enzyme gene insertion/deletion polymorphism, angiographically defined coronary artery disease and myocardial infarction in patients with type 2 diabetes mellitus.
    Narne P; Ponnaluri KC; Singh S; Siraj M; Ishaq M
    J Renin Angiotensin Aldosterone Syst; 2012 Dec; 13(4):478-86. PubMed ID: 22679279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of the genetic variants of endothelial nitric oxide synthase gene with angiographically defined coronary artery disease and myocardial infarction in South Indian patients with type 2 diabetes mellitus.
    Narne P; Ponnaluri KC; Singh S; Siraj M; Ishaq M
    J Diabetes Complications; 2013; 27(3):255-61. PubMed ID: 23182401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysglycemia and increased left ventricle mass in normotensive patients admitted with a first myocardial infarction: prognostic implications of dysglycemia during 14 years of follow-up.
    Pararajasingam G; Løgstrup BB; Høfsten DE; Christophersen TB; Auscher S; Hangaard J; Egstrup K
    BMC Cardiovasc Disord; 2019 May; 19(1):103. PubMed ID: 31046690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased risk of subsequent myocardial infarction in patients with type 2 diabetes: a retrospective cohort study using the U.K. General Practice Research Database.
    Liang H; Vallarino C; Joseph G; Manne S; Perez A; Zhang S
    Diabetes Care; 2014; 37(5):1329-37. PubMed ID: 24595635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of screening for coronary artery disease using CT angiography on mortality and cardiac events in high-risk patients with diabetes: the FACTOR-64 randomized clinical trial.
    Muhlestein JB; Lappé DL; Lima JA; Rosen BD; May HT; Knight S; Bluemke DA; Towner SR; Le V; Bair TL; Vavere AL; Anderson JL
    JAMA; 2014 Dec; 312(21):2234-43. PubMed ID: 25402757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiometabolic risk is associated with atherosclerotic burden and prognosis: results from the partners coronary computed tomography angiography registry.
    Hulten E; Bittencourt MS; O'Leary D; Shah R; Ghoshhajra B; Christman MP; Montana P; Steigner M; Truong QA; Nasir K; Rybicki F; Hainer J; Brady TJ; Di Carli MF; Hoffmann U; Abbara S; Blankstein R
    Diabetes Care; 2014 Feb; 37(2):555-64. PubMed ID: 24130364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale and design of the LURIC study--a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease.
    Winkelmann BR; März W; Boehm BO; Zotz R; Hager J; Hellstern P; Senges J;
    Pharmacogenomics; 2001 Feb; 2(1 Suppl 1):S1-73. PubMed ID: 11258203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated lipoprotein (a) levels are associated with the presence and severity of coronary artery disease in patients with type 2 diabetes mellitus.
    Zhang HW; Zhao X; Guo YL; Gao Y; Zhu CG; Wu NQ; Li JJ
    Nutr Metab Cardiovasc Dis; 2018 Oct; 28(10):980-986. PubMed ID: 30030022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Timing of randomization after an acute coronary syndrome in patients with type 2 diabetes mellitus.
    Elharram M; Sharma A; White W; Bakris G; Rossignol P; Mehta C; Ferreira JP; Zannad F
    Am Heart J; 2020 Nov; 229():40-51. PubMed ID: 32916607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mortality of Myocardial Infarction by Sex, Age, and Obstructive Coronary Artery Disease Status in the ACTION Registry-GWTG (Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With the Guidelines).
    Smilowitz NR; Mahajan AM; Roe MT; Hellkamp AS; Chiswell K; Gulati M; Reynolds HR
    Circ Cardiovasc Qual Outcomes; 2017 Dec; 10(12):e003443. PubMed ID: 29246884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elderly diabetics with peripheral arterial disease and no coronary artery disease have a higher incidence of new coronary events than elderly nondiabetics with peripheral arterial disease and prior myocardial infarction treated with statins and with no lipid-lowering drug.
    Aronow WS; Ahn C
    J Gerontol A Biol Sci Med Sci; 2003 Jun; 58(6):573-5. PubMed ID: 12807931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arg399Gln polymorphism of X-ray repair cross-complementing group 1 gene is associated with angiographically documented coronary artery disease in South Indian type 2 diabetic patients.
    Narne P; Ponnaluri KC; Singh S; Siraj M; Ishaq M
    Genet Test Mol Biomarkers; 2013 Mar; 17(3):236-41. PubMed ID: 23360319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EMPA-REG and Other Cardiovascular Outcome Trials of Glucose-lowering Agents: Implications for Future Treatment Strategies in Type 2 Diabetes Mellitus.
    Schernthaner G; Schernthaner-Reiter MH; Schernthaner GH
    Clin Ther; 2016 Jun; 38(6):1288-1298. PubMed ID: 27210264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low adiponectin levels and increased risk of type 2 diabetes in patients with myocardial infarction.
    Lindberg S; Jensen JS; Pedersen SH; Galatius S; Frystyk J; Flyvbjerg A; Bjerre M; Mogelvang R
    Diabetes Care; 2014 Nov; 37(11):3003-8. PubMed ID: 25078899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High plasma levels of macrophage migration inhibitory factor are associated with adverse long-term outcome in patients with stable coronary artery disease and impaired glucose tolerance or type 2 diabetes mellitus.
    Makino A; Nakamura T; Hirano M; Kitta Y; Sano K; Kobayashi T; Fujioka D; Saito Y; Watanabe K; Watanabe Y; Kawabata K; Obata JE; Kugiyama K
    Atherosclerosis; 2010 Dec; 213(2):573-8. PubMed ID: 20934703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk stratification by assessment of coronary artery disease using coronary computed tomography angiography in diabetes and non-diabetes patients: a study from the Western Denmark Cardiac Computed Tomography Registry.
    Olesen KKW; Riis AH; Nielsen LH; Steffensen FH; Nørgaard BL; Jensen JM; Poulsen PL; Thim T; Bøtker HE; Sørensen HT; Maeng M
    Eur Heart J Cardiovasc Imaging; 2019 Nov; 20(11):1271-1278. PubMed ID: 31220229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in clinical characteristics between patients with and without type 2 diabetes hospitalized with a first myocardial infarction.
    Kasteleyn MJ; Vos RC; Jansen H; Rutten GE
    J Diabetes Complications; 2016 Jul; 30(5):830-3. PubMed ID: 27134032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
    ; Bittl JA; Baber U; Bradley SM; Wijeysundera DN
    Circulation; 2016 Sep; 134(10):e156-78. PubMed ID: 27026019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thromboembolic Risk of Imaging-Confirmed Coronary Artery Disease Without Myocardial Infarction in Patients With Nonvalvular Atrial Fibrillation.
    Cho MS; Lee K; Choi KJ; Lee JB; Do U; Kim YN; Kim J; Nam GB; Kim YH
    Am J Cardiol; 2019 Apr; 123(8):1287-1292. PubMed ID: 30709601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.